Poorest countries granted TRIPs extension

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Poorest countries granted TRIPs extension

Some of the world’s poorest countries will have access to affordable medicine for another eight years after WTO members agreed to extend the deadline for them to implement intellectual property provisions under the TRIPs Agreement.

Last week, the WTO issued a decision to extend the deadline for what it calls the “least developed countries” until July 1 2021, and said that a further extension may be possible when the time comes.

The previous deadline, which has already been extended once before, was July 1 2013.

The decision was made on the first day of a two-day meeting of the Trade-Related Aspects of Intellectual Property Rights (TRIPs) Council. Members unanimously agreed to the extension but had to resolve different views on the terms through negotiation.

At present, the WTO recognises 49 jurisdictions as “least developed countries”. Of these, 34 are members of the WTO.

The extension does not provide exempt the countries from their other obligations under the TRIPs Agreement, such as a separate transition period for them to protect patents covering pharmaceutical inventions.

“The agreement reached by members makes very clear that we can come together and get things done,” said WTO Director-General Pascal Lamy in a statement.

more from across site and SHARED ros bottom lb

More from across our site

The Texas-based IP litigation hires take King & Spalding’s partner appointments from pre-merger Winston & Strawn up to 12 this year
Sunny Su explains how her team overcame challenges with orchard evidence collection to secure a favourable plant variety decision from China’s top court
Flexible working firm continues trajectory from 2025 with appointment of Matthew Grant and Letao Qin
Anousha Davies, associate and trademark attorney at Birketts, unpicks how the university’s reputation enabled it to see off a proposed trademark for ‘Cambridge Rowing’
IP lawyers, who say they are encouraging clients to build up ‘tariff resilience’, should treat the risks posed by recent orders as a core consideration in cross-border licensing
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Gift this article